chinese translation of a measure of symptom burden, functional limitations, lifestyle, and health care–seeking skills in breast cancer survivors: the cancer survivor profile

To produce a culturally sensitive chinese translation of the original version of the cancer survivor profile for breast cancer (cspro-bc) survivors, which identifies problems in breast cancer patients post-primary treatment for breast cancer. four hundred forty-four female chinese patients following primary treatment for breast cancer completed a chinese translation of the cspro-bc. participants were randomly divided into two equal groups (n = 222). the two samples were subjected to exploratory and confirmatory factor analysis. test-retest reliability, internal consistency, and divergent and convergent validities were also determined. the majority of participants were diagnosed with stage ii or iii breast cancer (76.1%), with a median of 16 months post-primary treatment, between the ages of 40–59, educated at the junior high school level or below (86.2%), married with children (93.7%), and unemployed (70.7%). factor analysis generated five factors: symptom burden, function, health behavior, financial strain, and health care–seeking skills. scales within each domain were similar to the original cspro-bc. the measurement models for symptom burden (cfi = 0.949, rmsea = 0.055), function (cfi = 0.925, rmsea = 0.080), health behavior (cfi = 0.999, rmsea = 0.015), financial strain (cfi = 0.999, rmsea = 0.014), and health care–seeking skills (cfi = 0.964, rmsea = 0.059) were all consistent with the original measure. test-retest reliability was between 0.80 and 0.92. internal consistency ranged from 0.65 to 0.95. discriminant and concurrent validities were consistent to the original. the translation resulted in a valid and reliable self-assessment tool for identifying common non-medical problems in breast cancer patients’ post-cancer treatment. a culturally sensitive measure of symptoms, functional limitations, lifestyle, and health care–seeking skills in chinese-speaking breast cancer survivors is available for further testing.